Oxaliplatin Treatment Alters Systemic Immune Responses.
Vanesa StojanovskaMonica PrakashRachel McQuadeSarah FraserVasso ApostolopoulosSamy SakkalKulmira NurgaliPublished in: BioMed research international (2019)
Oxaliplatin does not cause systemic immunosuppression and, instead, has the capacity to induce beneficial antitumor immune responses.